Modelling trajectories and mechanisms of childhood hip dysplasia

The HIPSTAR project aims to identify and prevent hip dysplasia in children to reduce the risk of developing osteoarthritis in adulthood by studying growth patterns and causal factors.

Subsidie
€ 2.499.373
2023

Projectdetails

Introduction

With 40 million patients in Europe, osteoarthritis (OA) is the most common chronic and disabling disease. OA is incurable, and symptomatic treatments have limited effect. Therefore, prevention by identifying and targeting asymptomatic persons that develop a clear OA risk factor is sorely needed.

Risk Factors for Osteoarthritis

Hip dysplasia is the strongest risk factor for hip OA. Hip dysplasia is a condition of mechanical instability of the hip caused by insufficient coverage of the femoral head (ball) by a shallow or obliquely oriented acetabulum (socket). This results in high cartilage stress, and subsequent hip OA.

Current Screening Practices

In Europe, we screen for developmental hip dysplasia in infants (prevalence 2%), enabling early treatment. However, we discovered that hip dysplasia can (further) develop during skeletal maturation and thus remains unrecognized.

Prevalence of Hip Dysplasia

In 1100 Dutch 9-year-old children, we found a 6% and 26% prevalence of marked and mild hip dysplasia, respectively. Hip dysplasia can be influenced until the stage where hip growth plates close at about age 13.

Proposed Research Program

I propose a novel research program (HIPSTAR) where I will uniquely unravel the mechanisms behind late childhood hip dysplasia in order to pave the way for devising preventive measures that reduce the prevalence of adult hip dysplasia and, thus, hip OA.

Research Methodology

In a birth cohort of 8000 children (followed from fetal life until adulthood), I will first uniquely build a 5D growth model on how hip shape develops over time from age 2-18 years.

  1. I will gain novel knowledge regarding causal factors of dysplastic growth.
  2. I will investigate whether there are various phenotypes that have different underlying mechanisms.
  3. I will study how and when dysplastic growth will already impact the integrity of the young adult joint.
  4. I will discover very early signs of joint aberration leading to OA.

Computational Modeling

Finally, in a computational model, I will test the influence of loading factors on dysplastic growth mechanistically, and provide detailed information regarding the potential remedial options.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.373
Totale projectbegroting€ 2.499.373

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2027
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAMpenvoerder
  • TECHNISCHE UNIVERSITEIT DELFT

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

EIC Transition

Development of a Complete Triple Action Injectable Treatment for Osteoarthritis

Relevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients.

€ 2.398.115
ERC POC

reGeneRative bone Implant for the treatment of hip dysPlasia

GRIP aims to revolutionize hip dysplasia treatment with personalized, 3D-printed regenerative bone implants, enhancing integration and reducing invasiveness compared to current methods.

€ 150.000
ERC COG

In Silico Trials for Cartilage Regenerative Medicine Applications

The INSTAnt CARMA project aims to develop and validate a multiscale in silico model for osteoarthritis to optimize drug and tissue-engineered therapies through virtual trials.

€ 2.212.385
ERC STG

Impact of the embryonic obesogenic environment on programming of cardiovascular diseases across the life course

OBESE-EMBRYO aims to improve cardiovascular health in future generations by targeting the embryonic obesogenic environment in overweight and obese parents-to-be through innovative, evidence-based interventions.

€ 1.499.998